The loss of ER expression in about one-fourth of recurrent oestrogen receptor-positive (ER+) breast cancer makes them immune to endocrine therapy and able to spread unchecked.

from mint - Science https://ift.tt/5mBJezN
https://ift.tt/PNWVJ8k

Post a Comment

أحدث أقدم